WEST PHARMACEUTICAL SERVICES, INC. Other Asset Impairment Charges
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Asset Impairment Charges of $2.70 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2023-02-21
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for the quarter ending 2021-12-31 was $700.00K, a 40.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for the quarter ending 2021-09-30 was $200.00K, a 77.78% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for the quarter ending 2021-06-30 was $200.00K, a 96.83% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for the quarter ending 2021-03-31 was $100.00K, a 50.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for fiscal 2022 was $2.70M, a 107.69% increase from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for fiscal 2021 was $1.30M, a 83.12% decline from fiscal 2020.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for fiscal 2020 was $7.70M, a 862.50% increase from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. other asset impairment charges for fiscal 2019 was $800.00K, a 55.56% decline from fiscal 2018.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2022-12-31 | $2.70M 10-K · filed 2023-02-21 | |||
| 2021-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $900.00K derived: sum of 2 quarters · filed 2023-02-21 | $1.10M derived: sum of 3 quarters · filed 2023-02-21 | $1.30M 10-K · filed 2023-02-21 |
| 2021-09-30 | $200.00K 10-Q · filed 2021-10-28 | $400.00K derived: sum of 2 quarters · filed 2021-10-28 | $600.00K 10-Q · filed 2021-10-28 | $1.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $200.00K 10-Q · filed 2021-07-30 | $300.00K 10-Q · filed 2021-07-30 | $800.00K derived: sum of 3 quarters · filed 2023-02-21 | $1.70M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $100.00K 10-Q · filed 2021-04-30 | $600.00K derived: sum of 2 quarters · filed 2023-02-21 | $1.50M derived: sum of 3 quarters · filed 2023-02-21 | $7.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.40M derived: sum of 2 quarters · filed 2023-02-21 | $7.70M derived: sum of 3 quarters · filed 2023-02-21 | $7.70M 10-K · filed 2023-02-21 |
| 2020-09-30 | $900.00K 10-Q · filed 2021-10-28 | $7.20M derived: sum of 2 quarters · filed 2021-10-28 | $7.20M 10-Q · filed 2021-10-28 | $5.90M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $6.30M 10-Q · filed 2021-07-30 | $6.50M 10-Q · filed 2021-07-30 | $5.00M derived: sum of 3 quarters · filed 2022-02-22 | $5.80M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $200.00K 10-Q · filed 2021-04-30 | -$1.30M derived: sum of 2 quarters · filed 2022-02-22 | -$500.00K derived: sum of 3 quarters · filed 2022-02-22 | $700.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$700.00K derived: sum of 2 quarters · filed 2022-02-22 | $500.00K derived: sum of 3 quarters · filed 2022-02-22 | $800.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $800.00K 10-Q · filed 2020-10-23 | $2.00M derived: sum of 2 quarters · filed 2020-10-23 | $2.30M 10-Q · filed 2020-10-23 | |
| 2019-06-30 | $1.20M 10-Q · filed 2020-07-24 | $1.60M 10-Q · filed 2020-07-24 | ||
| 2018-12-31 | $1.80M 10-K · filed 2021-02-23 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-02-25 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 10-K · filed 2015-02-25 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-04 | $0.00 derived: sum of 2 quarters · filed 2013-11-04 | $0.00 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $3.40M derived: sum of 3 quarters · filed 2015-02-25 | $3.40M 10-K · filed 2015-02-25 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-04 | $3.40M derived: sum of 2 quarters · filed 2013-11-04 | $3.40M 10-Q · filed 2013-11-04 | |
| 2012-06-30 | $3.40M 10-Q · filed 2013-08-05 | $3.40M 10-Q · filed 2013-08-05 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $0.00 derived: sum of 2 quarters · filed 2014-02-27 | $0.00 derived: sum of 3 quarters · filed 2014-02-27 | $0.00 10-K · filed 2014-02-27 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-05 | $0.00 derived: sum of 2 quarters · filed 2012-11-05 | $0.00 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-06 | $0.00 10-Q · filed 2012-08-06 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |